Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
09/2014
09/04/2014US20140249306 Hiv replication inhibitor
09/04/2014US20140249197 Novel indole derivatives as selective androgen receptor modulators (sarms)
09/04/2014US20140249196 N-benzylbenzimidazole modulators of pparg
09/04/2014US20140249159 Heterocyclic compounds
09/04/2014US20140249144 Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient
09/04/2014US20140249137 Pyrimidine compounds as tuberculosis inhibitors
09/04/2014US20140249135 Pim kinase inhibitors and methods of their use
09/04/2014US20140249134 Triazolyl pde10 inhibitors
09/04/2014US20140249133 Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases
09/04/2014US20140249127 Serine/threonine kinase inhibitors
09/04/2014US20140248378 Pyrimidinone compounds and their use
09/03/2014EP2772483A1 4-aminocarbazole compound and use of same
09/03/2014EP2771335A2 (4-phenylimidazol-2-yl) ethylamine derivatives useful as sodium channel modulators
09/03/2014EP2771334A1 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies
09/03/2014EP2771327A1 Novel pyrazine derivatives
09/03/2014EP2771326A1 Synthesis of triazolopyrimidine compounds
09/03/2014EP2771322A2 Novel trpv3 modulators
09/02/2014US8822685 2,4-pyrimidinediamine compounds and their uses
09/02/2014US8822526 Synergistic pharmaceutical combination for the treatment of cancer
09/02/2014US8822522 Dual-acting pyrazole antihypertensive agents
09/02/2014US8822520 Substituted bicyclic HCV inhibitors
09/02/2014US8822495 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
09/02/2014US8822486 Spiropiperidine compounds
09/02/2014US8822472 Piperazines, pharmaceutical compositions and methods of use thereof
09/02/2014US8822460 Fused cyclopentyl antagonists of CCR2
09/02/2014US8822452 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
09/02/2014US8822430 Antiviral compounds
09/02/2014US8822414 Heterocyclic compounds suitable for the treatment of dyslipidemia
09/02/2014CA2602467C Bcrp/abcg2 inhibitor
08/2014
08/28/2014WO2014130241A1 Fungicidal pyrazoles
08/28/2014WO2014129989A1 3-substituted-6h-benzo[c]chromen-6-ones and 3-substituted-7,8,9,10-tetrahydro-6h-benzo[c]chromen-6-ones against senile dementia
08/28/2014WO2014129846A1 Organic electroluminescent compounds and an organic electroluminescent device comprising the same
08/28/2014WO2014128622A1 Quinazolines as kinase inhibitors
08/28/2014WO2014128524A1 An improved process for preparation of an intermediate of the pyrrolidine substituted flavones
08/28/2014WO2014128523A1 A process for preparation of an intermediate of the pyrrolidine substituted flavones
08/28/2014WO2014128486A1 Pyrimidine compounds useful in the treatment of diseases mediated by ikke and/or tbk1 mechanisms
08/28/2014WO2014128223A1 Pyridine derivatives as 5-ht6 receptor antagonists
08/28/2014US20140243524 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
08/28/2014US20140243382 Inhibitors of c-fms kinase
08/28/2014US20140243381 Furyl and thienyl triazole derivatives and therapeutic uses thereof
08/28/2014US20140243374 Novel Sulfonamides
08/28/2014US20140243366 Compounds that modulate intracellular calcium
08/28/2014US20140243349 Gamma-diketones as wnt/beta -catenin signaling pathway activators
08/28/2014US20140243336 2-Pyridyl Carboxamide-Containing Spleen Tyrosine Kinase (SYK) Inhibitors
08/28/2014US20140243331 Inhibitors of inv(16) leukemia
08/28/2014US20140243309 Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors
08/28/2014US20140243308 Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
08/28/2014US20140243305 Azetidinyl diamides as monoacylglycerol lipase inhibitors
08/28/2014US20140243257 Benzimidazole analogues for the treatment or prevention of flavivirus infections
08/27/2014EP2769977A1 Heterocyclic Compound and Organic Light-Emitting Diode including the same
08/27/2014EP2768810A1 Compounds that modulate intracellular calcium
08/27/2014EP2768809A1 Pyridine- sulfoximines as tyrosine kinase inhibitors
08/27/2014EP2768805A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors
08/26/2014US8816093 Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
08/26/2014US8816092 Indazole derivative or salt thereof and production intermediate thereof, and antioxidant using same, and use of indazole derivative or salt thereof
08/26/2014US8815915 Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulators
08/26/2014US8815914 Positive allosteric modulators of nicotinic acetylcholine receptor
08/26/2014US8815907 Quaternary ammonium compounds useful as muscarinic receptor antagonists
08/26/2014US8815903 Indole derivative and pharmacologically acceptable salt thereof
08/26/2014US8815870 4-(2-(6-substituted-hexylidene) hydrazinyl)benzonitrile and preparation thereof
08/26/2014US8815864 Indanyloxydihydrobenzofuranylacetic acids
08/26/2014US8815855 N-sulphonylpyrroles and their use as histone deacetylase inhibitors
08/26/2014US8815851 Aminodihydrothiazine derivatives
08/26/2014CA2611443C Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
08/21/2014WO2014125426A1 Trisubstituted heterocyclic derivatives as ror gamma modulators
08/21/2014WO2014096388A3 Novel benzimidazole derivatives as kinase inhibitors
08/21/2014US20140235864 Biphenyl derivatives
08/21/2014US20140235723 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
08/21/2014US20140235675 3-oxo-2,3-dihydro-1h-indazole-4-carboxamide derivatives as parp-1 inhibitors
08/21/2014US20140235672 Chromene modulators of chemokine receptor activity
08/21/2014US20140235661 New ccr2 receptor antagonists and uses thereof
08/21/2014US20140235658 Quinazoline derivatives as kinases inhibitors and methods of use thereof
08/21/2014US20140235654 Use of derivatives of indoles for the treatment of cancer
08/21/2014US20140235642 Trpm8 antagonists and their use in treatments
08/21/2014US20140235641 Pyrazole carboxamides as janus kinase inhibitors
08/21/2014US20140235640 Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors
08/21/2014US20140235638 Anti-Infective Agents and Uses Thereof
08/21/2014US20140235637 Compounds and methods for treating inflammatory and fibrotic disorders
08/21/2014US20140235634 Therapeutic compounds and uses thereof
08/21/2014US20140235633 4-Aminoquinazoline Derivatives and Uses Thereof
08/21/2014US20140235628 Inhibitors of the Renal Outer Medullary Potassium Channel
08/21/2014US20140235622 Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
08/21/2014US20140235579 Heterocyclic compounds for the inhibition of pask
08/21/2014US20140235533 Dihydrofuran derivatives as insecticidal compounds
08/21/2014US20140234376 Substituted Benzoazepines as Toll-Like Receptor Modulators
08/21/2014US20140234333 Compositions and methods for inhibition of the jak pathway
08/21/2014US20140234245 N-(pyrid-4-yl)amides and n-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use
08/20/2014EP2767532A1 Novel compound for imaging tau protein accumulated in the brain
08/20/2014EP2766356A1 Quinazoline derivatives as kinases inhibitors and methods of use thereof
08/20/2014EP2766353A1 2-oxo-piperidinyl derivatives
08/20/2014EP2766352A1 Indazole compounds as kinase inhibitors and method of treating cancer with same
08/20/2014EP2766348A1 Benzodioxepin-3-one compounds as dyes or as fluorescent emitters
08/20/2014EP2766347A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
08/19/2014US8809545 Aryl pyridine as aldosterone synthase inhibitors
08/19/2014US8809536 2,3-dihydrobenzo[1,4] dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases
08/19/2014US8809525 1,2,4-triazine-4-amine derivatives
08/19/2014US8809383 Pyrazole compound
08/19/2014US8809367 1-1-Oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
08/19/2014US8809364 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
08/19/2014US8809333 Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 694